SEC Form 4Coverage since May 26, 2026
$TMCI insider trading
Over the last 12 months, Treace Medical Concepts insiders reported 4 buys totaling $829K and no sales across SEC Form 4 filings.
- Bought · 12m
- $829K 4 events
- Sold · 12m
- — 0 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $TMCI · 12Mvia TradingView
Top insiders · 12m
Treace John T.Chief Executive Officer4× · $829K
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Treace John T.Chief Executive Officer · O·D·10% | ▲ Buy | 24,606 | $4.03 | $99K | +0.3% | 2 tranches |
| Jun 11, 2026 | Treace John T.Chief Executive Officer · O·D·10% | ▲ Buy | 52,317 | $4.03 | $211K | +0.7% | 2 tranches |
| Jun 1, 2026 | Treace John T.Chief Executive Officer · O·D·10% | ▲ Buy | 50,000 | $3.56 | $178K | +0.7% | — |
| May 28, 2026 | Treace John T.Chief Executive Officer · O·D·10% | ▲ Buy | 115,520 | $2.95 | $341K | +1.6% | 3 tranches |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $TMCI feed.